Autori: Fleischmann Roy M
| Naslov | A Randomized, Double-Blind, Placebo-Controlled, Twelve-Week, Dose-Ranging Study of Decernotinib, an Oral Selective JAK-3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis (Article) |
| Autori | Fleischmann Roy M Damjanov Nemanja S Kivitz Alan J Legedza Anna Hoock Thomas Kinnman Nils |
| Info | ARTHRITIS & RHEUMATOLOGY, (2015), vol. 67 br. 2, str. 334-343 |
| Projekat | Vertex Pharmaceuticals Incorporated |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Dose Ranging Study of VX-509, An Oral Selective JAK3 Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis (RA). (Meeting Abstract) |
| Autori | Fleischmann Roy M Spencer-Green George T Fan Frank Frankovic Biliana Luo Xia Hoock Thomas Damjanov Nemanja S |
| Info | ARTHRITIS AND RHEUMATISM, (2011), vol. 63 br. 12, str. 4042-4042 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
